Humacyte Stock (NASDAQ: HUMAW) stock price, news, charts, stock research, profile.
Open | $2.93 |
Close | $3.07 |
Volume / Avg. | 77.10K / 40.41K |
Day Range | 2.76 - 3.10 |
52 Wk Range | 0.35 - 3.29 |
Market Cap | - |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Humacyte (NASDAQ:HUMAW) through any online brokerage.
Other companies in Humacyte’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
There is no analysis for Humacyte.
There is no analysis for Humacyte to provide a consensus price target.
The stock price for Humacyte (NASDAQ: HUMAW) is $2.95 last updated July 23, 2024 at 9:23 AM EDT.
There are no upcoming dividends for Humacyte.
Humacyte does not have any upcoming earnings scheduled.
There is no upcoming split for Humacyte.
Humacyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.